| Visualitzacions | |
|---|---|
| Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 52 |
| gener 2024 | febrer 2024 | març 2024 | abril 2024 | maig 2024 | juny 2024 | juliol 2024 | |
|---|---|---|---|---|---|---|---|
| Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 0 | 17 | 0 | 7 | 5 | 13 | 10 |
| Visualitzacions | |
|---|---|
| artconlli_a2018_tabernero_josep_efficacy_Sym004.pdf | 7 |
| Visualitzacions | |
|---|---|
| Estats Units | 34 |
| Xina | 7 |
| Canadà | 2 |
| Espanya | 1 |
| Visualitzacions | |
|---|---|
| Menlo Park | 24 |
| Shanghai | 6 |
| Oakland | 5 |
| San Diego | 4 |
| Ottawa | 2 |
| Barcelona | 1 |
| Guangzhou | 1 |
| Jackson | 1 |